Testing methods that cannot distinguish real particulate contamination from measurement artifacts or dissolved materials create the dangerous paradox of either rejecting acceptable products or releasing contaminated ones - both scenarios damage business and potentially patient safety. Light obscuration method validation for sub-visible particle analysis establishes that product-specific testing reliably quantifies particulate contamination despite potential interferences from product matrices, extractables, or solubility challenges that could compromise measurement accuracy. This comprehensive validation following Ph. Eur. 2.9.19, USP 788, ISO 21501-3, and AAMI TIR42 employs count standards at multiple size ranges to verify instrument performance, extraction recovery, and method precision under actual product testing conditions. Products with complex matrices - combination devices, drug-device products, or materials generating turbidity during extraction - require method validation demonstrating that particle counting distinguishes true particulate contamination from dissolved materials, air bubbles, or method artifacts that could generate false-positive results. The validation protocol employs standardized particle suspensions with known concentrations at 10 and 25 micron sizes, confirming that extraction procedures maintain particle integrity while efficiently transferring particles from products into measurement solutions without artificial generation or loss. For manufacturers developing novel products or implementing automated particle testing systems, validation provides documented evidence supporting regulatory submissions and demonstrating measurement capability appropriate to product specifications and patient safety requirements. Method validation identifies optimal extraction conditions balancing complete particle recovery against generation of method-related artifacts, establishing scientifically justified protocols that regulatory reviewers accept as reliable contamination measurement.